General Versus Regional Anesthesia in Peripheral Arterial Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

594

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

June 30, 2028

Conditions
Postoperative ComplicationsCardiovascular Diseases
Interventions
PROCEDURE

Spinal Anesthesia

Participants will receive subarachnoid (spinal) anesthesia with 15-20 mg of isobaric bupivacaine 0.5% and 100 μg of intrathecal morphine. Clonidine (1 μg/kg) may be added at the discretion of the anesthesiologist. Sedation will be achieved with intravenous midazolam (up to 5 mg), fentanyl (up to 100 μg), and/or target-controlled infusion of propofol. Patients will remain spontaneously breathing throughout the procedure and receive supplemental oxygen via nasal cannula.

PROCEDURE

General Anesthesia

Participants will undergo general anesthesia induced with intravenous propofol (1.5-2.5 mg/kg) or etomidate (0.2-0.3 mg/kg), remifentanil (0.2-0.4 μg/kg/min), and rocuronium (0.6 mg/kg), followed by endotracheal intubation and controlled mechanical ventilation. Maintenance will include continuous remifentanil infusion and inhaled sevoflurane. Ventilation parameters will follow a protective strategy (tidal volume 6-8 mL/kg predicted body weight and PEEP of 5 cmH₂O).

Trial Locations (1)

90035903

Andre Prato Schmidt, Porto Alegre

All Listed Sponsors
collaborator

Grupo Hospitalar Conceição

OTHER_GOV

lead

Hospital de Clinicas de Porto Alegre

OTHER